Frederik C Roos
Overview
Explore the profile of Frederik C Roos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
699
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wenzel M, Hoeh B, Ruhrup J, Gambetta H, Nocera L, Wurnschimmel C, et al.
Front Oncol
. 2022 Oct;
12:1019057.
PMID: 36300101
Background: Only one previously published study by Nocera et al. addressed the risk of upstaging to ≥pT3 in cT1 clear cell renal cell carcinoma (ccRCC) by using characteristics of the...
2.
Zschabitz S, Mikuteit M, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Discov Oncol
. 2022 Sep;
13(1):90.
PMID: 36136143
Background: Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and...
3.
Mondorf Y, Mikuteit M, Ivanyi P, Stohr C, Herrmann E, Polifka I, et al.
Urol Int
. 2022 Jun;
106(11):1168-1176.
PMID: 35654002
Introduction: Programmed death-1 ligand (PD-L1) has been often studied in different types of renal-cell carcinoma (RCC). For example, in clear-cell renal carcinoma it is well established that programmed death-1 receptor...
4.
Zschabitz S, Erlmeier F, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
J Cancer
. 2022 Apr;
13(6):1706-1712.
PMID: 35399715
Prostate specific membrane antigen (PSMA) is an emerging diagnostic and therapeutic target in prostate cancer. Ga-PSMA-labeled hybrid imaging is used for the detection of prostate primary tumors and metastases. Therapeutic...
5.
Mikuteit M, Zschabitz S, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Pathol Res Pract
. 2022 Feb;
231:153802.
PMID: 35180650
Background: Claudins are promising biomarkers for diagnosis and prognosis or targets for treatment. They play a major role in signal transduction and are important in nearly all aspects of tumorigenesis....
6.
Erlmeier F, Bruecher B, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Hum Pathol
. 2022 Jan;
121:1-10.
PMID: 34998840
The tyrosine-protein kinase c-Met plays a decisive role in numerous cellular processes, as a proto-oncogene that supports aggressive tumor behavior. It is still unknown whether c-Met could be relevant for...
7.
Kosiba M, Stolzenbach L, Colla Ruvolo C, Nocera L, Mansour M, Tian Z, et al.
Clin Genitourin Cancer
. 2021 Dec;
20(2):195.e1-195.e8.
PMID: 34906434
Objective: To test 1) contemporary pelvic lymph node dissection (PLND) trends at radical cystectomy (RC) in variant histology bladder cancer (VHBC) patients and urothelial carcinoma of the urinary bladder (UCUB),...
8.
Wenzel M, Nocera L, Wurnschimmel C, Colla Ruvolo C, Tian Z, Saad F, et al.
Front Oncol
. 2021 Oct;
11:754996.
PMID: 34692543
Background: This study aims to test the effect of the 10 most common nonurological primary cancers (skin, rectal, colon, lymphoma, leukemia, pancreas, stomach, esophagus, liver, lung) on overall mortality (OM)...
9.
Wenzel M, Hoeh B, Krimphove M, Buchholz C, Muller M, Garcia C, et al.
Urol Int
. 2021 Oct;
106(6):581-588.
PMID: 34601466
Purpose: This study aimed to evaluate the impact of preoperative double-J stent (DJ) in pyeloplasty patients on perioperative complications, recurrence, and quality of life (QoL). Methods: Pyeloplasties due to ureteropelvic...
10.
Wenzel M, Siron N, Colla Ruvolo C, Nocera L, Wurnschimmel C, Tian Z, et al.
Cancer Causes Control
. 2021 Sep;
33(1):25-35.
PMID: 34476653
Purpose: To compare Cancer-specific mortality (CSM) in patients with Squamous cell carcinoma (SCC) vs. non-SCC penile cancer, since survival outcomes may differ between histological subtypes. Methods: Within the Surveillance, Epidemiology...